H1N1 vaccination does not increase risk of relapse in multiple sclerosis: A self-controlled case-series study

Multiple Sclerosis Journal

Volumn 18, Issue 2, 2012, Pages 254-256

  Farez, Mauricio F ^a   Ysrraelit, María C ^a   Fiol, Marcela ^a   Correale, Jorge ^a  

^a FLENI   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLATIRAMER; INFLUENZA VACCINE; PLACEBO;

ADULT; CONTROLLED STUDY; DISEASE DURATION; DISEASE EXACERBATION; DRUG SAFETY; FOLLOW UP; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LETTER; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; QUESTIONNAIRE; RELAPSE; RISK ASSESSMENT;

EID: 84856692370     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511417253     Document Type: Letter

References (6)

1. Farez MF, Correale J. Immunizations and risk of multiple sclerosis: systematic review and meta-analysis. J Neurol. 2011 ; 258: 1197-1206
2. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Statist Med. 2006 ; 25: 1768-1797
3. Myers LW, Ellison GW, Lucia M, et al. Swine influenza virus vaccination in patients with multiple sclerosis. J Infect Dis. 1977 ; 136 (Suppl.). S546 - S554
4. Miller AE, Morgante LA, Buchwald LY, et al. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology. 1997 ; 48: 312-314 (Pubitemid 27087594)
5. Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med. 2001 ; 344: 319-326 (Pubitemid 32107639)
6. McNicholas N, Chataway J. Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination. J Neurol. 2011 ;: